Windtree Therapeutics, Inc. WINT
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow WINT
| Sep '25 | Jun '25 | Mar '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.01 | 0.02 | 0.18 | 0.31 | |
Current Ratio |
0.33 | 0.43 | 0.25 | 0.45 | |
Net Debt/EBITDA |
(0.88) | (1.89) | 0.16 | 0.15 | |
Debt/Assets |
107.82% | 24.45% | 2.02% | 3.44% | |
Debt/Equity |
(1.48) | 2.16 | 0.05 | 0.10 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.22 | 0.18 | 0.48 | (54.19) | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.50 | 0.76 | 0.90 | 0.87 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.24) | (0.54) | (2.21) | (70.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.24) | (0.54) | (2.21) | (70.06) | |
Cash per Share |
0.01 | 0.06 | 1.08 | 33.82 | |
Shareholders Equity per Share |
(0.44) | 0.74 | 9.45 | 190.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.44) | 0.74 | 9.45 | 190.04 | |
Free Cash Flow |
(6.37) | (2.66) | (2.41) | (3.68) | |
Working Capital |
(14.70) | (8.94) | (4.88) | (3.14) | |
Capital Expenditures |
— | — | — | 0.00 | |
Net Current Asset Value |
(20.39) | (21.43) | (14.88) | (15.30) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.85 | 3.55 | 2.40 | 1.34 | |
Average Assets |
23.22 | 30.27 | 28.43 | 30.14 | |
Average Common Equity |
(3.60) | 3.55 | 12.86 | 6.69 |
Columns are period end dates